Jiayi Wu
Adult Health · Chevy Chase, MDNPI 1124856984
Payments from drug & device makers
Across 35 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$121
- Boehringer Ingelheim$97
- Pfizer$85
- E.r. Squibb & Sons, L.L.C.$82
- Bridgebio Pharma, Inc.$60
- Novartis$56
- plus $298 from 12 others
What the payments were for
- Food & beverage$799100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $121 |
| Boehringer Ingelheim | 4 | $97 |
| Pfizer | 4 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $82 |
| Bridgebio Pharma, Inc. | 2 | $60 |
| Novartis | 2 | $56 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Inspire Medical Systems, Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| Edwards Lifesciences | 1 | $23 |
| Heartflow, Inc. | 1 | $22 |
| Boston Scientific | 1 | $16 |
| AstraZeneca | 1 | $15 |
| GSK | 1 | $15 |
| Exact Sciences | 1 | $14 |
How this compares
$799 in reported general payments places this provider in the 60th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 26 | $9,672 |
| Oxycodone Hcl | 185 | $2,253 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 80 | $1,318 |
| Gabapentin | 79 | $699 |
| Cyclobenzaprine Hcl | 96 | $698 |
| Naloxone Hcl | 11 | $687 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $571 |
| Pregabalin | 39 | $522 |
| Celecoxib | 13 | $440 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $330 |
| Baclofen | 25 | $260 |
| Nabumetone | 33 | $192 |
| Duloxetine Hcl | 24 | $183 |
| Methocarbamol | 23 | $142 |
| Tramadol Hcl | 16 | $62 |
Paid to pharmacies, not to this prescriber.
Other adult health in Chevy Chase
- Lucia NovakCamp Springs$473K
- Caroline RuhlAnnapolis$315K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Angie PriceBaltimore$96K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Jane KapustinClarksville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.